WHEN Aimee Chapman began using fat jabs just over a year ago, she never expected to end up in hospital fighting for her life, ...

Novo Nordisk's current product portfolio is well-protected by patents until at least 2030. Click here to see why NVO stock is ...

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

A new study led by York University, looking at the health data of nearly 15,000 people enrolled in a medically supervised ...

The drug known as Wegovy is being tested in Canada as a treatment for MASH, formerly known as fatty liver disease. CTV's Pauline Chan has the details.

WEDNESDAY, May 14, 2025 (HealthDay News) — More U.S. teenagers are getting weight-loss surgery, despite the discovery of new ...

Weight-loss jabs have been hailed as the key to longer life even if you are not overweight, according to experts.

Weight-loss drugs like Ozempic and Wegovy could usher in a “golden age” of medicine due to their ability to delay diseases associated with ageing.

DelveInsight's analysis forecasts liver fibrosis market growth due to the introduction of emerging therapies, expecting an increase in market ...

The NHS has been urged to accelerate the rollout of weight loss drugs to “many millions” of people, as experts hailed the start of a “golden age” of anti-obesity treatments. A raft of studies ...

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

Discover how metabolic dysfunction-associated steatohepatitis (MASH) damages your liver, its connection to common health ...